Wellstat Therapeutics Corporation discovers, develops and commercializes products that will provide new and improved treatments for patients in the fields of oncology, metabolic, neurometabolic, and neurodegenerative diseases.
Sensei Biotherapeutics
Sensei Biotherapeutics is an immuno-oncology company that is dedicated to understanding and selectively interacting with the tumor microenvironment in order to tilt the immune system against cancer.
OS Therapies
OS Therapies (OST) is a clinical-stage therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS).
OTraces
OTraces Inc. is a provider of advanced oncology diagnostic systems.
Paradigm Shift Therapeutics
Paradigm Shift Therapeutics is a biotechnology research institute that develops inhibitors for treating patients with cancer.
NCI CIRB
NCI CIRB is a non-profit institute that helps and protects the rights of patients selected for medical trials of cancer medicines.
NeoDiagnostix
NeoDiagnostix is committed to pioneering the field of personalized medicine through cancer genomics.
NovaBridge Biosciences
NovaBridge Biosciences is a biotechnology platform that develops precision immuno-oncology treatment of cancer.